COVID-19 Update | October 30, 2020

COVID-19 News

COVID-19 Update | October 30, 2020

October 30, 2020

The California Biotechnology Foundation is committed to keeping you up to date about COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of October 30, 2020. Notable advancements include:

  • Regeneron released positive clinical trial data for its monoclonal antibody drugs and sought emergency use authorization from the U.S. Food and Drug Administration.
  • Novavax announced it plans to begin phase 3 clinical trials in the United States and Mexico by the end of November.
  • Gilead Sciences has received formal approval from the Food and Drug Administration for its drug remdesivir.

​Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.

Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new

If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or [email protected].